Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs
Author:
- 25 August 2007
- book chapter
- Published by Springer Nature
- p. 37-82
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cellsBiopharmaceutics & Drug Disposition, 2000
- Nucleoside transporters: molecular biology and implications for therapeutic developmentMolecular Medicine Today, 1999
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- The oligopeptide transporter (Pept-1) in human intestine: Biology and functionGastroenterology, 1997
- pGlu-L-Dopa-Pro: A Tripeptide Prodrug Targeting the Intestinal Peptide Transporter for Absorption and Tissue Enzymes for ConversionPharmaceutical Research, 1995
- Utilization of Peptide Carrier System To Improve Intestinal Absorption: Targeting Prolidase as a Prodrug-Converting EnzymeJournal of Pharmaceutical Sciences, 1992
- Structural Requirements for the Intestinal Mucosal-Cell Peptide Transporter: The Need for N-Terminal α-Amino GroupPharmaceutical Research, 1991
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Concentration and pH dependency of α-methyldopa absorption in rat intestineJournal of Pharmacy and Pharmacology, 1986
- Absorption and passage of fat- and water-soluble thiamin derivatives into erythrocytes and cerebrospinal fluid of manThe American Journal of Clinical Nutrition, 1974